PolyPid Ltd. financial data

Symbol
PYPD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
18 Hasivim Street, Petach Tikva, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
6-K - Q2 2024 - Aug 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.65M shares -91.7%
Common Stock, Shares, Outstanding 4.8M shares -90.2%
Weighted Average Number of Shares Outstanding, Basic 5.02M shares +240%
Weighted Average Number of Shares Outstanding, Diluted 5.02M shares +240%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.76M USD +20.2%
General and Administrative Expense 1.1M USD -27.1%
Operating Income (Loss) -6.12M USD -5.17%
Nonoperating Income (Expense) -171K USD -2343%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.29M USD -7.98%
Income Tax Expense (Benefit) 2K USD -80%
Net Income (Loss) Attributable to Parent -6.29M USD -7.83%
Earnings Per Share, Basic 1.25 USD/shares -68.4%
Earnings Per Share, Diluted 1.25 USD/shares -68.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.08M USD -9.42%
Cash, Cash Equivalents, and Short-term Investments 9.35M USD -38.1%
Assets, Current 9.78M USD -37.9%
Property, Plant and Equipment, Net 6.81M USD -20.1%
Operating Lease, Right-of-Use Asset 2.68M USD +41.6%
Other Assets, Noncurrent 257K USD +189%
Assets 19.5M USD -25.6%
Employee-related Liabilities, Current 958K USD -17.9%
Accrued Liabilities, Current 995K USD -20.1%
Liabilities, Current 10.3M USD +88.7%
Long-term Debt and Lease Obligation 6.38M USD -15.8%
Contract with Customer, Liability, Noncurrent 2.55M USD
Operating Lease, Liability, Noncurrent 1.59M USD +70.8%
Other Liabilities, Noncurrent 371K USD -16.8%
Retained Earnings (Accumulated Deficit) -251M USD -10.9%
Stockholders' Equity Attributable to Parent 1.6M USD -80.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 28.8M USD -56.4%
Liabilities and Equity 19.5M USD -25.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 108M shares 0%
Common Stock, Shares, Issued 4.8M shares -90.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.48M USD -12.3%
Deferred Tax Assets, Valuation Allowance 44.3M USD +9.62%
Deferred Tax Assets, Gross 44.7M USD +8.95%
Operating Lease, Liability 2.47M USD
Lessee, Operating Lease, Liability, to be Paid 2.81M USD
Property, Plant and Equipment, Gross 15.4M USD +1.29%
Operating Lease, Liability, Current 873K USD +36.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 919K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 958K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +10.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 346K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 455K USD
Deferred Tax Assets, Operating Loss Carryforwards 40.1M USD +14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 184K USD
Additional Paid in Capital 236M USD +7.24%
Operating Leases, Future Minimum Payments, Due in Two Years 358K USD
Operating Leases, Future Minimum Payments Due, Next Twelve Months 403K USD
Deferred Tax Assets, Net of Valuation Allowance 338K USD -39.5%
Operating Leases, Future Minimum Payments, Due in Three Years 349K USD
Operating Leases, Future Minimum Payments Due 1.57M USD